Found: 81
Select item for more details and to access through your institution.
Relapsed mantle cell lymphoma manifesting with soft tissue tumors of the extremities: University of Miami experience and review of the literature.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4581, doi. 10.1007/s00277-024-05997-1
- By:
- Publication type:
- Article
Atypical follicular hyperplasia with light chain–restricted germinal centers after COVID-19 booster: a diagnostic pitfall.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 5, p. 905, doi. 10.1007/s00428-022-03400-w
- By:
- Publication type:
- Article
Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 811, doi. 10.1007/s00432-021-03847-5
- By:
- Publication type:
- Article
The Evolving Role of <sup>18</sup>F-FDG PET Scans in Patients with Aggressive non-Hodgkin's Lymphoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004).
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0537-5
- By:
- Publication type:
- Article
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 7, p. 2616, doi. 10.1172/JCI64503
- By:
- Publication type:
- Article
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 6, p. 2516, doi. 10.1172/JCI64503
- By:
- Publication type:
- Article
MiR-181 family-specific behavior in different cancers: a meta-analysis view.
- Published in:
- Cancer & Metastasis Reviews, 2018, v. 37, n. 1, p. 17, doi. 10.1007/s10555-017-9714-9
- By:
- Publication type:
- Article
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1762, doi. 10.1111/bjh.19419
- By:
- Publication type:
- Article
A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 76, doi. 10.1111/bjh.18368
- By:
- Publication type:
- Article
EBV‐positive HIV‐associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 5, p. 870, doi. 10.1111/bjh.17708
- By:
- Publication type:
- Article
Central nervous system emergencies in haematological malignancies.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1028, doi. 10.1111/bjh.16184
- By:
- Publication type:
- Article
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 524, doi. 10.1111/bjh.15720
- By:
- Publication type:
- Article
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 4, p. 514, doi. 10.1111/bjh.12915
- By:
- Publication type:
- Article
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 640, doi. 10.1111/bjh.12801
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article
LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 621, doi. 10.1111/bjh.12440
- By:
- Publication type:
- Article
Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 639, doi. 10.1111/bjh.12449
- By:
- Publication type:
- Article
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
- Published in:
- Nature Genetics, 2014, v. 46, n. 2, p. 166, doi. 10.1038/ng.2873
- By:
- Publication type:
- Article
Cyclosporin A Upmodulates Bleomycin-Induced Pulmonary Fibrosis in BALB/c Mice.
- Published in:
- Respiration, 2002, v. 69, n. 4, p. 344, doi. 10.1159/000063273
- By:
- Publication type:
- Article
Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 300, doi. 10.1002/ajh.26784
- By:
- Publication type:
- Article
Long‐term outcomes of patients with conjunctival extranodal marginal zone lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 148, doi. 10.1002/ajh.26591
- By:
- Publication type:
- Article
Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1529, doi. 10.1002/ajh.26715
- By:
- Publication type:
- Article
A roadmap for clinical trial design in marginal zone lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1398, doi. 10.1002/ajh.26706
- By:
- Publication type:
- Article
R‐MACLO‐IVAM regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma ‐ Long term follow up results.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 680, doi. 10.1002/ajh.26163
- By:
- Publication type:
- Article
Biased Use of the IGHV4 Family and Evidence for Antigen Selection in Chlamydophila psittaci-Negative Ocular Adnexal Extranodal Marginal Zone Lymphomas.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0029114
- By:
- Publication type:
- Article
Sudden hearing loss following acute hepatitis.
- Published in:
- Postgraduate Medical Journal, 1999, p. 309, doi. 10.1136/pgmj.75.883.309
- By:
- Publication type:
- Article
Rare PTCLs: Treatment Lagging Behind Pathobiologic Advances.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 1, p. 101
- By:
- Publication type:
- Article
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5221, doi. 10.3390/cancers14215221
- By:
- Publication type:
- Article
Treatments and Outcomes in Stage I Extranodal Marginal Zone Lymphoma in the United States.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1803, doi. 10.3390/cancers13081803
- By:
- Publication type:
- Article
Ultrasound diagnosis and follow-up of testicular monocytic leukemia.
- Published in:
- 1997
- By:
- Publication type:
- journal article
KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.
- Published in:
- American Journal of Clinical Pathology, 2017, v. 148, n. 6, p. 465, doi. 10.1093/AJCP/AQX099
- By:
- Publication type:
- Article
Oral and Extraoral Plasmablastic Lymphoma: Similarities and Differences in Clinicopathologic Characteristics.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Oral and Extraoral Plasmablastic Lymphoma.
- Published in:
- American Journal of Clinical Pathology, 2010, v. 134, n. 5, p. 710, doi. 10.1309/AJCPJH6KEUSECQLU
- By:
- Publication type:
- Article
Expression of LMO2 Is Associated With t(14;18)/IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell Lymphoma.
- Published in:
- American Journal of Clinical Pathology, 2010, v. 134, n. 2, p. 278, doi. 10.1309/AJCPATUP1D0HGCUG
- By:
- Publication type:
- Article
C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.
- Published in:
- American Journal of Clinical Pathology, 2009, v. 132, n. 1, p. 39, doi. 10.1309/AJCPZQ1GXBBNG8OG
- By:
- Publication type:
- Article
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors.
- Published in:
- EMBO Journal, 2012, v. 31, n. 18, p. 3704, doi. 10.1038/emboj.2012.227
- By:
- Publication type:
- Article
Clinical and radiological characteristics of patients with pulmonary marginal zone lymphoma: A single center analysis.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 5051, doi. 10.1002/cam4.3096
- By:
- Publication type:
- Article
Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
- Published in:
- Cancer (0008543X), 2000, v. 88, n. 7, p. 1599, doi. 10.1002/(SICI)1097-0142(20000401)88:7<1599::AID-CNCR14>3.0.CO;2-J
- By:
- Publication type:
- Article
PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.
- Published in:
- FEBS Journal, 2011, v. 278, n. 17, p. 3065, doi. 10.1111/j.1742-4658.2011.08227.x
- By:
- Publication type:
- Article
Germinal center-specific protein human germinal center associated lymphoma directly interacts with both myosin and actin and increases the binding of myosin to actin.
- Published in:
- FEBS Journal, 2011, v. 278, n. 11, p. 1922, doi. 10.1111/j.1742-4658.2011.08109.x
- By:
- Publication type:
- Article
Mantle cell lymphoma involving the thyroid gland.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Frontline brentuximab vedotin in breast implant‐associated anaplastic large‐cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S393, doi. 10.1016/S2152-2650(21)01892-9
- By:
- Publication type:
- Article
Poster: ABCL-351: Promising Tolerability and Efficacy Results from Dose-Escalation in an Ongoing Phase Ib/II Study of Mosunetuzumab with Polatuzumab Vedotin (Pola) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S241, doi. 10.1016/S2152-2650(21)01516-0
- By:
- Publication type:
- Article
Progress and Challenges in the Treatment of Follicular Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S179, doi. 10.1016/j.clml.2017.08.082
- By:
- Publication type:
- Article
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00539-8
- By:
- Publication type:
- Article
Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall.
- Published in:
- Case Reports in Hematology, 2018, p. 1, doi. 10.1155/2018/5761953
- By:
- Publication type:
- Article